LENZ Therapeutics, Inc. (LENZ)
3.15
0.00 (0.00%)
USD |
NASDAQ |
Oct 27, 16:00
3.21
+0.06
(+1.90%)
After-Hours: 20:00
LENZ Therapeutics Price : 3.15 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 3.13 | 3.19 | 3.075 | 3.15 | 377751.0 |
| Oct 26, 2026 | 3.16 | 3.195 | 3.095 | 3.145 | 389145.0 |
| Oct 23, 2026 | 3.23 | 3.23 | 3.06 | 3.16 | 696455.0 |
| Oct 22, 2026 | 3.25 | 3.285 | 3.18 | 3.25 | 435473.0 |
| Oct 21, 2026 | 3.20 | 3.37 | 3.145 | 3.22 | 943347.0 |
| Oct 20, 2026 | 3.27 | 3.33 | 3.12 | 3.19 | 819366.0 |
| Oct 19, 2026 | 3.27 | 3.40 | 3.209 | 3.30 | 648751.0 |
| Oct 16, 2026 | 3.56 | 3.56 | 3.21 | 3.27 | 939082.0 |
| Oct 15, 2026 | 3.43 | 3.64 | 3.43 | 3.57 | 793846.0 |
| Oct 14, 2026 | 3.39 | 3.615 | 3.345 | 3.43 | 1.040M |
| Oct 13, 2026 | 3.62 | 3.62 | 3.395 | 3.40 | 603727.0 |
| Oct 12, 2026 | 3.64 | 3.71 | 3.60 | 3.61 | 603479.0 |
| Oct 09, 2026 | 3.53 | 3.65 | 3.42 | 3.645 | 625764.0 |
| Oct 08, 2026 | 3.58 | 3.61 | 3.35 | 3.53 | 1.037M |
| Oct 07, 2026 | 3.72 | 3.72 | 3.58 | 3.62 | 515502.0 |
| Oct 06, 2026 | 3.60 | 3.84 | 3.60 | 3.79 | 682818.0 |
| Oct 05, 2026 | 3.60 | 3.60 | 3.455 | 3.59 | 777424.0 |
| Oct 02, 2026 | 3.84 | 3.84 | 3.51 | 3.58 | 1.127M |
| Oct 01, 2026 | 3.85 | 3.91 | 3.79 | 3.79 | 738896.0 |
| Sep 30, 2026 | 3.90 | 3.90 | 3.75 | 3.84 | 786205.0 |
| Sep 29, 2026 | 3.96 | 3.97 | 3.79 | 3.86 | 645153.0 |
| Sep 28, 2026 | 3.89 | 3.995 | 3.68 | 3.96 | 712696.0 |
| Sep 25, 2026 | 3.75 | 4.00 | 3.66 | 3.915 | 923819.0 |
| Sep 24, 2026 | 3.75 | 3.75 | 3.595 | 3.72 | 1.009M |
| Sep 23, 2026 | 4.14 | 4.14 | 3.735 | 3.76 | 765642.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Impact BioMedical, Inc. | 3.55 |
| Enveric Biosciences, Inc. | 1.42 |
| Liquidia Corp. | 45.44 |
| Aquestive Therapeutics, Inc. | 4.07 |
| ANI Pharmaceuticals, Inc. | 71.17 |
Price Related Metrics
| PS Ratio | 4.486 |
| PEG Ratio | -0.0067 |
| Price to Book Value | 0.4513 |
| Earnings Yield | -129.6% |
| Market Cap | 98.96M |
| PEGY Ratio | -0.0067 |